10-97460125-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000438925.7(MMS19):c.2577A>T(p.Glu859Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000438925.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMS19 | NM_022362.5 | c.2577A>T | p.Glu859Asp | missense_variant | 26/31 | ENST00000438925.7 | NP_071757.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMS19 | ENST00000438925.7 | c.2577A>T | p.Glu859Asp | missense_variant | 26/31 | 1 | NM_022362.5 | ENSP00000412698 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250872Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135590
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461692Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727126
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74514
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2023 | The c.2577A>T (p.E859D) alteration is located in exon 26 (coding exon 26) of the MMS19 gene. This alteration results from a A to T substitution at nucleotide position 2577, causing the glutamic acid (E) at amino acid position 859 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at